iCAD, Inc. (ICAD)
NASDAQ: ICAD · IEX Real-Time Price · USD
1.300
-0.060 (-4.41%)
At close: Jul 19, 2024, 4:00 PM
1.380
+0.080 (6.15%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
iCAD, Inc. Employees
As of December 31, 2023, iCAD, Inc. had 69 total employees, including 67 full-time and 2 part-time employees. The number of employees decreased by 40 or -36.70% compared to the previous year.
Employees
69
Change (1Y)
-40
Growth (1Y)
-36.70%
Revenue / Employee
$284,522
Profits / Employee
-$33,203
Market Cap
34.50M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Nutex Health | 800 |
Achilles Therapeutics | 215 |
Exagen | 179 |
Retractable Technologies | 151 |
Aadi Bioscience | 89 |
IceCure Medical | 77 |
Xilio Therapeutics | 73 |
IGC Pharma | 67 |
ICAD News
- 26 days ago - iCAD to Highlight Promising Research on Potential of its AI Algorithm to More Accurately Identify and Personalize Breast Cancer Risk at SIIM 2024 - GlobeNewsWire
- 6 weeks ago - iCAD to Participate in the MedInvest MedTech, AI & Digital Health Conference - GlobeNewsWire
- 2 months ago - iCAD Reports Financial Results for First Quarter Ended March 31, 2024 - GlobeNewsWire
- 2 months ago - UPDATE - iCAD to Report First Quarter 2024 Financial Results on May 15, 2024 - GlobeNewsWire
- 2 months ago - iCAD to Report First Quarter 2024 Financial Results on May 15, 2024 - GlobeNewsWire
- 3 months ago - iCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium - GlobeNewsWire
- 3 months ago - iCAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation - GlobeNewsWire
- 3 months ago - iCAD's ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting - GlobeNewsWire